Back to search

Article

Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

2023-06-22

Abstract excerpt

<h4>Background</h4> The standard initial treatment for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (nCRT). In order to select patients who would benefit the most from nCRT, there is a strong need for predictive biomarkers. The aim of this study was to evaluate the role of clinical, pathological, radiological, inflammation-related genetic, and hematological parameters in the prediction of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d267f14c-5637-5494-a7b4-58147b3bbdd2
DOI
10.1101/2023.06.20.23291673
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerDOI 10.1101/2023.06.20.23291673
Select a neighboring publication to make it the new centre.